Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed

Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed CluePoints, the Tufts Center for the Study of Drug Development and PwC publish Comprehensive Assessment of RBQM Adoption in Clinical Trials.

New study explores how Switzerland can maintain its leading position in life science innovation

The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity Reports: “Sustaining a winning position” – an analysis of how Switzerland can continue to lead the life sciences sector in a shifting global market.

Integrated DNA Technologies Unveils New Custom Vector Onboarding Tool to Optimize Gene Synthesis

Global genomics solutions provider Integrated DNA Technologies (IDT) is expanding its gene synthesis offerings with a new custom vector onboarding tool.

North Carolina Takes the Lead in PFAS Research with Collaboratory's $3 Million Investment to Expand the State's Research Capacity

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments

Illumina Throws Weight Behind National Initiative to Assess Potential of Exhaustive Genomic Profiling in Advanced Cancer Real-World Scenario Across Belgium

SIRIO launches personalised women’s health platform at Vitafoods Europe

New ready-to-launch formulation range features premium branded ingredients, and targets issues as diverse as PMS, fertility, prenatal & postnatal care and menopause wellbeing.

Phastar’s Clinical Intelligence Portal Shortlisted as Finalist in 2024 Citeline Award

Phastar, a global specialist biometrics contract research organization (CRO), has been selected as finalist for the Best Sponsor-facing Technology Initiative at the Citeline Awards 2024. Phastar were recognised for the launch of their Clinical Intelligence Portal, and notably the comprehensive recruitment forecasting app within that suite.

CluePoints’ Site Profile & Oversight Tool (SPOT) shortlisted as finalist in 2024 Citeline Awards

CluePoints, providers of best-in-class statistical and AI-driven software solutions, has been shortlisted as finalist for the Best Sponsor-facing Technology Initiative in the 2024 Citeline Awards. CluePoints was recognized for its Site Profile & Oversight Tool (SPOT), - due to launch to the market in June 2024 – and was developed collaboratively, based on market needs, with two large pharmaceutical clients of CluePoints who helped provide direction and feedback regarding the required features and functionalities.

Visit Watson-Marlow Fluid Technology Solutions at booth 3521 during INTERPHEX 2024 for exclusive technology previews and insights

Watson-Marlow Fluid Technology Solutions (WMFTS) will preview two new technologies at booth 3521 during INTERPHEX 2024, 16-18th April 2024, Javits Center, NYC, USA.

FemTech and Women’s Health start-ups urged to join Discovery Park’s growth programme, offering a support package worth over £50K

Discovery Park, Kent’s thriving life science community, has launched a special edition of their growth and support programme, Discovery Spark, for start-ups in FemTech and Women’s Health. Now open for applications, the programme offers tailored mentoring and support for start-ups, preparing founders for success in investment pitches. Companies will compete to win a support package worth over £50K, including 1 year of lab or office space at Discovery Park, alongside invaluable support from healthcare partners, Barclays Eagle Labs and six specialist prize partners.

CD Formulation Introduces Microneedle Patch Innovations for Enhanced Drug Delivery Efficiency

Alfa Chemistry Expands Offering of Polymer Fibers: Polyester Fiber, Polyamide Fiber, Aromatic Polyamide Fiber, and Polyacrylonitrile Fiber

New Study Links Patients with Multiple Phenotypes to Higher Body Weight and BMI

Research from Mayo Clinic published in Nature’s International Journal of Obesity introduces new insights into obesity precision medicine for patients with more than one phenotype.

Phreesia Announces Jack Callahan as New Chief Technology Officer

Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company’s new Chief Technology Officer.

ENPICOM secures financing from BOP Capital, BOM Brabant Ventures and brings Dr. Colby Souders on board as a new investor

Investment to bolster international partnerships and advance AI-driven solutions for antibody discovery

Alfa Chemistry's MS and NMR Center Enables Fast, Cost-Effective Laboratory Analytical Testing

ResultsCX Named ‘Promising Provider’ in Everest Group’s Service Provider Compass™ – Global Services Delivery from Mexico Report

CD Formulation Incorporates Phase Separation Method for Microsphere Production

ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors

ReciBioPharm partners with GeneVentiv Therapeutics to advance first AAV-based gene therapy for haemophilia patients